AZN and CGEN Related Headlines

Go Back

Aug 26, 2026 07:00AM Daiichi Sankyo and AstraZeneca start phase 3 urothelial cancer trial
Aug 26, 2026 07:00AM TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

AZN and CGEN Related Press Releases

Go Back

Aug 26, 2026 07:00AM TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

AZN and CGEN Related SEC Filings

Go Back